Showing results (101-110 of 343) with videos related to
Sort By:
Pageof 35
Gut|June 14, 2022
COVID-19 and liver diseaseJean-François Dufour, Thomas Marjot, Chiara Becchetti, et al.Gut|November 26, 2024
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonistsGiovanni Targher, Alessandro Mantovani, Christopher D Byrne, et al.Nature Reviews. Gastroenterology & Hepatology|May 2, 2018
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver diseaseQuentin M Anstee, Alessandro Mantovani, Herbert Tilg, et al.Cell Host & Microbe|April 15, 2016
Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota AlterationsAlexander R Moschen, Romana R Gerner, Jun Wang, et al.Cancers|July 24, 2021
Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma DevelopmentRuben Bellotti, Cornelia Speth, Timon E Adolph, et al.Nature Reviews. Gastroenterology & Hepatology|September 29, 2019
Translating the gut microbiome: ready for the clinic?Susan V Lynch, Siew C Ng, Fergus Shanahan, et al.Molecular Aspects of Medicine|May 24, 2020
Intravenous iron supplementation therapyBenedikt Schaefer, Eva Meindl, Sonja Wagner, et al.Canadian Journal of Physiology and Pharmacology|October 15, 2013
Metabolic inflammation: role of cytokines in the crosstalk between adipose tissue and liverRomana R Gerner, Verena Wieser, Alexander R Moschen, et al.Gut|March 19, 2017
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseasesLeon A Adams, Quentin M Anstee, Herbert Tilg, et al.Nature Reviews. Gastroenterology & Hepatology|November 10, 2025
IL-1 family of cytokines in gastrointestinal and liver disordersJulian Schwärzler, Paola Menghini, Charles Dinarello, et al.Pageof 35